L Ni, C Dong - Molecular cancer therapeutics, 2017 - AACR
T cells are the main effector cells in immune response against tumors. The activation of T cells is regulated by the innate immune system through positive and negative costimulatory …
B Venkatesh, AP Lee, V Ravi, AK Maurya, MM Lian… - Nature, 2014 - nature.com
The emergence of jawed vertebrates (gnathostomes) from jawless vertebrates was accompanied by major morphological and physiological innovations, such as hinged jaws …
The B7‐CD 28 family of ligands and receptors play important roles in T‐cell co‐stimulation and co‐inhibition. Phylogenetically they can be divided into three groups. The recent …
Utilization of negative checkpoint regulators (NCR s) for cancer immunotherapy has garnered significant interest with the completion of clinical trials demonstrating efficacy …
Y Deng, M Shi, L Yi, MN Khan, Z Xia, X Li - Heliyon, 2024 - cell.com
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by producing remarkable clinical outcomes for patients with various cancer types. However, only a subset …
R Zhao, JM Chinai, S Buhl… - Proceedings of the …, 2013 - National Acad Sciences
T-cell costimulation and coinhibition generated by engagement of the B7 family and their receptor CD28 family are of central importance in regulating the T-cell response, making …
Abstract Purpose: HHLA2 (B7H7/B7-H5/B7y) is a newly identified B7 family member that regulates human T-cell functions. However, its protein expression in human organs and …
T Glatzer, M Killig, J Meisig, I Ommert… - Immunity, 2013 - cell.com
RORγt+ innate lymphoid cells (ILCs) are crucial players of innate immune responses and represent a major source of interleukin-22 (IL-22), which has an important role in mucosal …
Gastric cancer (GC), with a heterogeneous nature, is the third leading cause of death worldwide. Over the past few decades, stable reductions in the incidence of GC have been …